Perfect Holding SA (“Perfect Holding”) has acquired Kinarus AG (“Kinarus”) via reverse takeover (RTO). Kinarus shareholders representing 95.3% of its share capital have tendered their shares in exchange for newly issued shares of Perfect Holding.
Kinarus is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic diseases.
The combined entity will be renamed to Kinarus Therapeutics Holding AG and trade on SIX Swiss Exchange with the ticker symbol “KNRS”.
